白质
多发性硬化
医学
疾病
神经影像学
病理
磁共振成像
扩大残疾状况量表
成像生物标志物
队列
无线电技术
磁共振弥散成像
多重比较问题
病变
临床孤立综合征
阿尔茨海默病神经影像学倡议
表型
灰色(单位)
高强度
神经科学
相关性
中枢神经系统疾病
基因检测
生物信息学
肿瘤科
临床表型
神经遗传学
内科学
遗传倾向
灰质
生物标志物
作者
Paolo Preziosa,Loredana Storelli,Ferdinando Clarelli,Elisabetta Pagani,Nicolò Tedone,Monica Margoni,Federica Esposito,Antonio Gallo,Alessandro d’Ambrosio,Massimo Filippi,Maria Assunta Rocca
出处
期刊:Brain
[Oxford University Press]
日期:2026-09-21
卷期号:149 (11): 4018-4034
标识
DOI:10.1093/brain/awag320
摘要
Multiple sclerosis is characterized by marked biological heterogeneity that is only partly captured by conventional clinical phenotypes and age-at-onset categories. MRI can detect focal lesions, diffuse microstructural damage and atrophy, but these measures are usually considered separately. We therefore aimed to use Subtype and Stage Inference (SuStaIn), an unsupervised machine learning framework, to identify biologically meaningful MRI subtypes of multiple sclerosis and determine their associations with disability, age at onset, cognition, genetic susceptibility to more severe disease and relapse-independent progression. We applied SuStaIn to multimodal 3 T brain MRI data from 1017 patients with multiple sclerosis and 548 healthy controls. Imaging features included T2-hyperintense white matter lesion volume, mean diffusivity in white matter lesions and major white matter tracts, and cortical and deep grey matter volumes. Cognitive testing was available in 501 patients, genetic profiling in 650, and longitudinal clinical follow-up in 645 (median follow-up = 6.57 years). An independent validation cohort included 247 patients with multiple sclerosis and 141 healthy controls. SuStaIn identified four MRI subtypes: lesion-led (44%), cortex-led (23%), tract-led (23%) and deep grey matter/cerebellar-led (10%). Cortex-led and deep grey matter/cerebellar-led subtypes were enriched in progressive disease (47% and 56%), whereas lesion-led and tract-led subtypes were predominantly relapsing-remitting disease (66% and 71%; P < 0.001). The tract-led subtype was over-represented in paediatric-onset disease (38%) and under-represented in adult-onset disease (19%); the lesion-led subtype predominated in adult-onset disease (48%) and the deep grey matter/cerebellar-led subtype was more frequent in late-onset disease (14%) (P < 0.001). Expanded Disability Status Scale scores ≥4.0 and ≥6.0 were more frequent in cortex-led and deep grey matter/cerebellar-led disease than in lesion-led or tract-led disease (45.3% and 55.6% versus 34.3% and 31.9%, and 27.8% and 29.3% versus 20.0% and 18.7%; P < 0.001). Relapse-independent progression-free survival differed across subtypes (P = 0.04) and was 1.67 and 1.93 years shorter in cortex-led and deep grey matter/cerebellar-led disease, respectively, than in lesion-led disease (P < 0.001). Cognitive performance and genetic risk scores for multiple sclerosis severity did not differ across subtypes, but within each subtype advancing SuStaIn stage was associated with worse global and domain-specific cognitive performance (all P ≤ 0.030). The four-subtype structure was reproduced in the independent validation cohort. Multimodal MRI analysed with SuStaIn identified reproducible subtypes of multiple sclerosis with clinically meaningful differences in phenotype, age at onset, disability and relapse-independent progression, while cognitive impairment was related to advancing SuStaIn stage within each subtype. This framework may support biologically informed patient stratification and more mechanism-based prognostic and therapeutic approaches in multiple sclerosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI